118 related articles for article (PubMed ID: 9267490)
1. Flow cytometric and immunohistochemical correlations in high incidence human solid tumors.
Danesi DT; Spanò M; Antonini F; Altavista P; Catalano P; Cordelli E; Pasqualetti P; Santacroce C; Toscano MG; Mecozzi A; Fabiano A
Tumori; 1997; 83(3):689-97. PubMed ID: 9267490
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients.
Danesi DT; Spanò M; Fabiano A; Altavista P; Pasqualetti P; Toscano MG; Antonini F; Catalano P; Mecozzi A; Picconi A; Daffinà A; Cucchiara G
Cytometry; 2000 Feb; 42(1):27-34. PubMed ID: 10679740
[TBL] [Abstract][Full Text] [Related]
3. Correlation between immunohistochemical expression of proliferating cell nuclear antigen and flow cytometry parameters in colorectal neoplasia.
Lazaris AC; Davaris P; Nakopoulou L; Theodoropoulos GE; Koullias G; Golematis BC
Dis Colon Rectum; 1994 Nov; 37(11):1083-9. PubMed ID: 7956574
[TBL] [Abstract][Full Text] [Related]
4. Polymorphous low-grade adenocarcinoma: flow cytometric, p53, and PCNA analysis.
Kelsch RD; Bhuiya T; Fuchs A; Gentile P; Kahn MA; Fantasia JE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):391-9. PubMed ID: 9347503
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
6. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
7. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
8. Cytometric DNA analysis and prognostic biomarkers in breast carcinoma. Expression of P53 product in the different ploidy classes.
Leonardi E; Cristofori A; Caffo O; Dalla Palma P
Anal Cell Pathol; 1997; 15(1):31-45. PubMed ID: 9373711
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
10. DNA aneuploidy in relation to the combination of analysis of estrogen receptor, progesterone receptor, p53 protein and epidermal growth factor receptor in 498 breast cancers.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Oncology; 2002; 63(1):48-55. PubMed ID: 12187071
[TBL] [Abstract][Full Text] [Related]
11. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
Dabbs DJ
Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
13. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
14. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
Levesque MA; Clark GM; Yu H; Diamandis EP
Br J Cancer; 1995 Sep; 72(3):720-7. PubMed ID: 7545416
[TBL] [Abstract][Full Text] [Related]
15. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
Pinto AE; André S; Pereira T; Silva G; Soares J
Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
17. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein.
Leal CB; Schmitt FC; Bento MJ; Maia NC; Lopes CS
Cancer; 1995 Apr; 75(8):2123-31. PubMed ID: 7697603
[TBL] [Abstract][Full Text] [Related]
18. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
[TBL] [Abstract][Full Text] [Related]
19. Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.
Railo M; Lundin J; Haglund C; von Smitten K; von Boguslawsky K; Nordling S
Acta Oncol; 1997; 36(4):369-74. PubMed ID: 9247096
[TBL] [Abstract][Full Text] [Related]
20. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
Prasad AR; Divine G; Zarbo RJ
Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
